AIM: To examine whether polymorphisms in SULT1A1 and GSTP1 genes contribute to colorectal cancer development and whether they are associated with clinicopathological variables are not well identified. METHODS: We examined the genotypes of 125 colorectal cancer patients and 666 healthy controls in a Swedish population by using PCR-restriction fragment length polymorphism (RFLP). RESULTS: SULT1A1 *2/*2 genotype (OR=2.49, 95%CI=1.48-4.19, P=0.0002) and *2 allele (OR=1.56, 95%CI=1.16-2.10, P=0.002) had an effect on colorectal cancer susceptibility, while GSTP1 genotype was without effect. However, GSTP1 G-type predicted a worse prognosis in the patients independently of gender, age, Dukes' stage, growth pattern, and differentiation (P=0.03). CONCLUSION: Polymorphism in SULT1A1 may predispose to colorectal cancer and GSTP1 may be a biological indicator of prognosis in the patients.
AIM: To examine whether polymorphisms in SULT1A1 and GSTP1 genes contribute to colorectal cancer development and whether they are associated with clinicopathological variables are not well identified. METHODS: We examined the genotypes of 125 colorectal cancerpatients and 666 healthy controls in a Swedish population by using PCR-restriction fragment length polymorphism (RFLP). RESULTS:SULT1A1 *2/*2 genotype (OR=2.49, 95%CI=1.48-4.19, P=0.0002) and *2 allele (OR=1.56, 95%CI=1.16-2.10, P=0.002) had an effect on colorectal cancer susceptibility, while GSTP1 genotype was without effect. However, GSTP1 G-type predicted a worse prognosis in the patients independently of gender, age, Dukes' stage, growth pattern, and differentiation (P=0.03). CONCLUSION: Polymorphism in SULT1A1 may predispose to colorectal cancer and GSTP1 may be a biological indicator of prognosis in the patients.
Authors: D Ryberg; V Skaug; A Hewer; D H Phillips; L W Harries; C R Wolf; D Ogreid; A Ulvik; P Vu; A Haugen Journal: Carcinogenesis Date: 1997-07 Impact factor: 4.944
Authors: T Katoh; S Kaneko; S Takasawa; N Nagata; H Inatomi; K Ikemura; H Itoh; T Matsumoto; T Kawamoto; D A Bell Journal: Pharmacogenetics Date: 1999-04
Authors: V Nedelcheva Kristensen; T I Andersen; B Erikstein; G Geitvik; E Skovlund; J M Nesland; A L Børresen-Dale Journal: Pharmacogenetics Date: 1998-10
Authors: Jan Stoehlmacher; David J Park; Wu Zhang; Susan Groshen; Denice D Tsao-Wei; Mimi C Yu; Heinz-Josef Lenz Journal: J Natl Cancer Inst Date: 2002-06-19 Impact factor: 13.506
Authors: Susan Nowell; Brian Coles; Rashmi Sinha; Stewart MacLeod; D Luke Ratnasinghe; Craig Stotts; Fred F Kadlubar; Christine B Ambrosone; Nicholas P Lang Journal: Mutat Res Date: 2002-09-30 Impact factor: 2.433
Authors: Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew Journal: Adv Cancer Res Date: 2019-04-23 Impact factor: 6.242
Authors: Jung Mook Kang; Nayoung Kim; Sung-Il Cho; Dong Ho Lee; Young Soo Park; Yu Rim Kim; Ji Hyun Park; Mi Kyoung Lee; Joo Sung Kim; Hyun Chae Jung; In Sung Song Journal: Gut Liver Date: 2008-06-30 Impact factor: 4.519
Authors: S D Ramsey; R S Holmes; C L McDermott; D K Blough; K L Petrin; E M Poole; C M Ulrich Journal: Colorectal Dis Date: 2012-09 Impact factor: 3.788
Authors: Kenneth D Tew; Yefim Manevich; Christina Grek; Ying Xiong; Joachim Uys; Danyelle M Townsend Journal: Free Radic Biol Med Date: 2011-04-22 Impact factor: 7.376
Authors: Sean P Cleary; Michelle Cotterchio; Ellen Shi; Steven Gallinger; Patricia Harper Journal: Am J Epidemiol Date: 2010-10-11 Impact factor: 4.897
Authors: Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano Journal: Front Pharmacol Date: 2018-09-19 Impact factor: 5.810